Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Feb 25 | Sale | 19.16 | 266 | 5,097 | 278,253 | Feb 25 06:33 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Feb 24 | Sale | 19.12 | 163 | 3,117 | 280,263 | Feb 24 06:04 PM | Gleeson Michael | SVP, Corp. Accounts | Feb 24 | Sale | 19.12 | 2,463 | 47,093 | 410,493 | Feb 25 06:32 PM | Shaw Christine | VP, Assay Development | Feb 24 | Sale | 19.12 | 259 | 4,952 | 105,621 | Feb 25 06:32 PM | Gleeson Michael | SVP, Corp. Accounts | Feb 23 | Sale | 19.35 | 1,432 | 27,709 | 412,956 | Feb 25 06:32 PM | Shaw Christine | VP, Assay Development | Feb 23 | Sale | 19.35 | 166 | 3,212 | 105,880 | Feb 25 06:32 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Feb 22 | Sale | 20.36 | 290 | 5,904 | 281,496 | Feb 22 07:02 PM | Winkler Sarah Hollis | VP, Human Resources | Feb 19 | Sale | 21.80 | 654 | 14,257 | 158,683 | Feb 22 07:04 PM | Gleeson Michael | SVP, Corp. Accounts | Feb 19 | Sale | 21.80 | 2,340 | 51,012 | 414,388 | Feb 22 07:03 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Feb 18 | Sale | 21.68 | 500 | 10,840 | 214,097 | Feb 22 06:59 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Feb 11 | Sale | 22.00 | 10,000 | 220,000 | 214,597 | Feb 16 05:17 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Feb 04 | Sale | 14.69 | 500 | 7,345 | 224,597 | Feb 08 05:10 PM | Winkler Sarah Hollis | VP, Human Resources | Jan 27 | Sale | 14.06 | 783 | 11,009 | 140,587 | Jan 29 05:14 PM | Shaw Christine | VP, Assay Development | Jan 27 | Sale | 14.06 | 81 | 1,139 | 79,796 | Jan 29 05:15 PM | Harkins Michael John | SVP, Sales | Jan 27 | Sale | 14.06 | 1,117 | 15,705 | 144,742 | Jan 29 05:14 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Jan 27 | Sale | 14.06 | 322 | 4,527 | 225,097 | Jan 29 05:16 PM | O'Brien Scott Alexander | SVP, Global Mktg & Int'l Sales | Jan 27 | Sale | 14.06 | 180 | 2,531 | 144,965 | Jan 29 05:15 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Jan 26 | Sale | 15.19 | 6,214 | 94,391 | 261,106 | Jan 29 05:16 PM | Mendel Scott | President & CEO | Jan 25 | Sale | 14.23 | 64,975 | 924,594 | 478,028 | Jan 25 08:35 PM | Harkins Michael John | SVP, Sales | Jan 25 | Sale | 14.22 | 7,338 | 104,346 | 145,859 | Jan 25 08:36 PM | Stier Eric | SVP & General Counsel | Jan 25 | Sale | 14.22 | 29,658 | 421,737 | 277,619 | Jan 25 08:35 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Jan 25 | Sale | 14.22 | 23,764 | 337,924 | 267,320 | Jan 25 08:35 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Jan 25 | Sale | 14.23 | 20,953 | 298,161 | 225,419 | Jan 25 08:37 PM | O'Brien Scott Alexander | SVP, Global Mktg & Int'l Sales | Jan 25 | Sale | 14.23 | 6,458 | 91,897 | 145,145 | Jan 25 08:36 PM | Winkler Sarah Hollis | VP, Human Resources | Jan 25 | Sale | 14.22 | 10,317 | 146,708 | 141,370 | Jan 25 08:36 PM | Ek John Frederick | Chief Financial Officer | Jan 25 | Sale | 14.24 | 18,475 | 263,084 | 210,258 | Jan 25 08:36 PM | Gleeson Michael | SVP, Corp. Accounts | Jan 25 | Sale | 14.22 | 33,027 | 469,644 | 397,978 | Jan 25 08:37 PM | Mendel Scott | President & CEO | Jan 21 | Option Exercise | 0.00 | 146,172 | 0 | 543,002 | Jan 21 08:09 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Jan 21 | Option Exercise | 0.00 | 65,185 | 0 | 291,084 | Jan 22 06:25 PM | Harkins Michael John | SVP, Sales | Jan 21 | Option Exercise | 0.00 | 19,166 | 0 | 153,197 | Jan 25 08:36 PM | Stier Eric | SVP & General Counsel | Jan 21 | Option Exercise | 0.00 | 77,240 | 0 | 307,277 | Jan 25 08:35 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Jan 21 | Option Exercise | 0.00 | 56,864 | 0 | 246,372 | Jan 25 08:37 PM | O'Brien Scott Alexander | SVP, Global Mktg & Int'l Sales | Jan 21 | Option Exercise | 0.00 | 16,666 | 0 | 151,603 | Jan 25 08:36 PM | Winkler Sarah Hollis | VP, Human Resources | Jan 21 | Option Exercise | 0.00 | 27,511 | 0 | 151,687 | Jan 25 08:36 PM | Ek John Frederick | Chief Financial Officer | Jan 21 | Option Exercise | 0.00 | 50,449 | 0 | 228,733 | Jan 25 08:36 PM | Gleeson Michael | SVP, Corp. Accounts | Jan 21 | Option Exercise | 0.00 | 83,836 | 0 | 431,005 | Jan 25 08:37 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Jan 21 | Sale | 14.93 | 500 | 7,465 | 189,508 | Jan 25 08:37 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Jan 20 | Sale | 15.00 | 5,000 | 75,000 | 225,899 | Jan 22 06:25 PM | Mendel Scott | President & CEO | Jan 19 | Sale | 14.54 | 50,000 | 727,000 | 115,491 | Jan 21 08:09 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Jan 07 | Option Exercise | 11.96 | 31,500 | 376,665 | 222,485 | Jan 08 06:01 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Jan 07 | Sale | 16.99 | 32,477 | 551,784 | 190,008 | Jan 08 06:01 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Jan 06 | Sale | 16.00 | 16,823 | 269,168 | 190,985 | Jan 08 06:01 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Dec 24 | Sale | 15.00 | 500 | 7,500 | 207,808 | Dec 29 06:32 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Dec 21 | Sale | 15.00 | 15,000 | 225,000 | 230,899 | Dec 22 05:42 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Dec 10 | Sale | 12.79 | 500 | 6,395 | 208,308 | Dec 11 05:51 PM | O'Brien Scott Alexander | SVP, Global Mktg & Int'l Sales | Dec 07 | Sale | 13.97 | 742 | 10,366 | 134,937 | Dec 09 05:24 PM | Shaw Christine | VP, Assay Development | Dec 07 | Sale | 13.97 | 274 | 3,828 | 79,877 | Dec 09 05:24 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Nov 27 | Sale | 12.42 | 500 | 6,210 | 208,186 | Dec 01 05:48 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Nov 25 | Sale | 12.72 | 552 | 7,021 | 245,899 | Nov 25 05:28 PM | Ek John Frederick | Chief Financial Officer | Nov 24 | Sale | 13.17 | 1,418 | 18,675 | 178,284 | Nov 25 05:30 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Nov 24 | Sale | 13.17 | 1,132 | 14,908 | 208,686 | Nov 25 05:29 PM | Shaw Christine | VP, Assay Development | Nov 24 | Sale | 13.17 | 355 | 4,675 | 79,291 | Nov 25 05:29 PM | Mendel Scott | President & CEO | Nov 24 | Sale | 13.17 | 5,190 | 68,352 | 396,830 | Nov 25 05:29 PM | Stier Eric | SVP & General Counsel | Nov 24 | Sale | 13.17 | 2,512 | 33,083 | 230,037 | Nov 25 05:28 PM | Gleeson Michael | SVP, Corp. Accounts | Nov 24 | Sale | 13.17 | 3,234 | 42,592 | 347,169 | Nov 25 05:28 PM | O'Brien Scott Alexander | SVP, Global Mktg & Int'l Sales | Nov 24 | Sale | 13.17 | 1,144 | 15,066 | 135,679 | Nov 25 05:29 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Nov 24 | Sale | 13.17 | 1,994 | 26,261 | 246,451 | Nov 24 07:53 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Nov 20 | Sale | 13.01 | 366 | 4,762 | 248,445 | Nov 24 07:53 PM | Mendel Scott | President & CEO | Nov 19 | Sale | 13.85 | 3,987 | 55,220 | 402,020 | Nov 20 06:09 PM | Stier Eric | SVP & General Counsel | Nov 19 | Sale | 13.85 | 1,555 | 21,537 | 232,549 | Nov 20 06:09 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Nov 19 | Sale | 13.85 | 1,310 | 18,144 | 248,811 | Nov 20 06:10 PM | Ek John Frederick | Chief Financial Officer | Nov 19 | Sale | 13.85 | 1,637 | 22,672 | 179,702 | Nov 20 06:10 PM | Gleeson Michael | SVP, Corp. Accounts | Nov 19 | Sale | 13.85 | 1,637 | 22,672 | 350,403 | Nov 20 06:10 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Nov 19 | Sale | 13.85 | 1,146 | 15,872 | 209,818 | Nov 20 06:08 PM | Winkler Sarah Hollis | VP, Human Resources | Nov 19 | Sale | 13.85 | 656 | 9,086 | 124,176 | Nov 20 06:09 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Nov 12 | Sale | 13.68 | 500 | 6,840 | 210,964 | Nov 13 05:34 PM | Stier Eric | SVP & General Counsel | Nov 11 | Sale | 12.77 | 59,293 | 757,172 | 234,104 | Nov 13 05:35 PM | O'Brien Scott Alexander | SVP, Global Mktg & Int'l Sales | Nov 03 | Sale | 12.73 | 212 | 2,699 | 136,823 | Nov 04 06:46 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Oct 29 | Sale | 11.32 | 500 | 5,660 | 211,464 | Oct 29 06:07 PM | Winkler Sarah Hollis | VP, Human Resources | Oct 27 | Sale | 11.34 | 765 | 8,675 | 124,832 | Oct 29 06:06 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Oct 27 | Sale | 11.34 | 220 | 2,495 | 211,964 | Oct 29 06:07 PM | Shaw Christine | VP, Assay Development | Oct 27 | Sale | 11.34 | 68 | 771 | 79,646 | Oct 29 06:09 PM | O'Brien Scott Alexander | SVP, Global Mktg & Int'l Sales | Oct 27 | Sale | 11.34 | 177 | 2,007 | 137,035 | Oct 29 06:10 PM | Harkins Michael John | SVP, Sales | Oct 27 | Sale | 11.34 | 1,092 | 12,383 | 132,982 | Oct 29 06:12 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Oct 15 | Sale | 11.83 | 500 | 5,915 | 209,765 | Oct 16 05:01 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Oct 07 | Option Exercise | 12.76 | 58,680 | 748,786 | 319,870 | Oct 09 06:35 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Oct 07 | Sale | 15.00 | 69,749 | 1,046,235 | 250,121 | Oct 09 06:35 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Oct 01 | Sale | 14.46 | 500 | 7,230 | 210,265 | Oct 02 07:37 PM | Ek John Frederick | Chief Financial Officer | Sep 22 | Sale | 13.82 | 41,196 | 569,329 | 181,339 | Sep 24 05:58 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Sep 17 | Sale | 12.72 | 500 | 6,360 | 210,765 | Sep 18 05:39 PM | Ek John Frederick | Chief Financial Officer | Sep 16 | Sale | 12.98 | 5,723 | 74,285 | 222,535 | Sep 18 05:40 PM | O'Brien Scott Alexander | SVP, Global Mktg & Int'l Sales | Sep 08 | Sale | 11.02 | 770 | 8,485 | 137,212 | Sep 10 06:16 PM | Shaw Christine | VP, Assay Development | Sep 08 | Sale | 11.02 | 285 | 3,141 | 79,714 | Sep 10 06:14 PM | Mitchell Brian Andrew | SVP, Operations | Sep 08 | Sale | 11.02 | 4,000 | 44,080 | 166,651 | Sep 10 05:45 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Sep 03 | Sale | 12.20 | 500 | 6,100 | 211,265 | Sep 04 05:44 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Aug 27 | Sale | 13.10 | 891 | 11,672 | 261,190 | Aug 28 05:54 PM | Mendel Scott | President & CEO | Aug 26 | Sale | 15.02 | 50,000 | 751,000 | 81,690 | Aug 28 05:53 PM | Mitchell Brian Andrew | SVP, Operations | Aug 26 | Sale | 14.74 | 3,464 | 51,059 | 170,651 | Aug 26 06:32 PM | Mitchell Brian Andrew | SVP, Operations | Aug 25 | Sale | 14.14 | 2,083 | 29,454 | 174,115 | Aug 26 06:32 PM | Mendel Scott | President & CEO | Aug 25 | Sale | 14.14 | 4,532 | 64,082 | 489,808 | Aug 26 06:30 PM | Stier Eric | SVP & General Counsel | Aug 25 | Sale | 14.14 | 2,684 | 37,952 | 293,397 | Aug 26 06:29 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Aug 25 | Sale | 14.14 | 2,130 | 30,118 | 262,081 | Aug 26 06:28 PM | Jensen Tyler | SVP, Engineering and Tech Dev | Aug 25 | Sale | 14.14 | 1,211 | 17,124 | 211,765 | Aug 26 06:27 PM | Ek John Frederick | Chief Financial Officer | Aug 25 | Sale | 14.14 | 1,515 | 21,422 | 228,258 | Aug 26 06:18 PM | Shaw Christine | VP, Assay Development | Aug 25 | Sale | 14.14 | 379 | 5,359 | 79,999 | Aug 26 06:17 PM | Gleeson Michael | SVP, Corp. Accounts | Aug 25 | Sale | 14.14 | 2,904 | 41,063 | 352,040 | Aug 26 06:15 PM | O'Brien Scott Alexander | SVP, Global Mktg & Int'l Sales | Aug 25 | Sale | 14.14 | 1,223 | 17,293 | 137,982 | Aug 26 06:14 PM | Mitchell Brian Andrew | SVP, Operations | Aug 21 | Sale | 15.62 | 2,997 | 46,813 | 176,198 | Aug 24 06:11 PM | Mendel Scott | President & CEO | Aug 20 | Sale | 15.41 | 2,988 | 46,045 | 494,340 | Aug 24 06:13 PM | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | Aug 20 | Sale | 15.41 | 1,353 | 20,850 | 264,211 | Aug 24 06:12 PM |
|